126 related articles for article (PubMed ID: 11145513)
21. Biologic therapy in psoriatic arthritis mutilans.
Peixoto D; Teixeira F; Bogas M; Costa J; Araújo D
Acta Reumatol Port; 2011; 36(2):189-90. PubMed ID: 21841743
[No Abstract] [Full Text] [Related]
22. Etanercept for psoriasis: two case reports.
Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of etanercept on cutaneous and joint lesions in psoriatic arthritis.
Mizote Y; Nakahara T; Mitoma C; Nakao M; Mitoma H; Moroi Y; Furue M
J Dermatol; 2012 Mar; 39(3):284-5. PubMed ID: 21950550
[No Abstract] [Full Text] [Related]
24. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
[No Abstract] [Full Text] [Related]
25. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
Girolomoni G; Abeni D
Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
[No Abstract] [Full Text] [Related]
26. Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial.
Kimball AB; Jackson JM; Sobell JM; Boh EE; Grekin S; Pharmd EB; Woolley JM; Xia HA; Chiou CF; Stevens SR
J Drugs Dermatol; 2007 Mar; 6(3):299-306. PubMed ID: 17373192
[TBL] [Abstract][Full Text] [Related]
27. Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.
van Luijn JC; Danz M; Bijlsma JW; Gribnau FW; Leufkens HG
Scand J Rheumatol; 2011 May; 40(3):183-91. PubMed ID: 20858147
[TBL] [Abstract][Full Text] [Related]
28. Psoriatic onychopachydermoperiostitis: improvement with etanercept.
Dans M; Hivnor C; van Voorhees AS
Br J Dermatol; 2005 Oct; 153(4):858-9. PubMed ID: 16181482
[No Abstract] [Full Text] [Related]
29. [Innovative therapeutic options for psoriatic arthritis: TNFalpha inhibitors].
Lehnen M; Goos M; Dissemond J
Dtsch Med Wochenschr; 2004 Mar; 129(12):634-8. PubMed ID: 15011134
[No Abstract] [Full Text] [Related]
30. Psoriatic arthritis patients doing better on infliximab than etanercept.
Smith N; Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
[No Abstract] [Full Text] [Related]
31. [The role of biological agents in the treatment of psoriatic arthritis, literature review].
Koó E; Brodszky V; Péntek M; Ujfalussy I; Nagy MB; Gulácsi L
Orv Hetil; 2006 Oct; 147(41):1963-70. PubMed ID: 17120686
[TBL] [Abstract][Full Text] [Related]
32. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
33. [Remission--therapy goal in rheumatoid arthritis].
Z Rheumatol; 2007 Feb; 66(1):2 p following 87. PubMed ID: 17896425
[No Abstract] [Full Text] [Related]
34. [Risks and side effect reactions during therapy with TNF-alpha blockers. An immunologic analysis].
Berg PA
Dtsch Med Wochenschr; 2004 Jul; 129(30):1631-4. PubMed ID: 15257503
[No Abstract] [Full Text] [Related]
35. Etanercept for the treatment of psoriasis and psoriatic arthritis.
Gottlieb AB
Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
[TBL] [Abstract][Full Text] [Related]
36. Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis.
Rottem M; Mader R
J Rheumatol; 2010 Jan; 37(1):209. PubMed ID: 20040647
[No Abstract] [Full Text] [Related]
37. Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis.
Chimenti MS; Teoli M; Di Stefani A; Giunta A; Esposito M; Perricone R
Eur J Dermatol; 2013 Apr; 23(2):273-4. PubMed ID: 23557629
[No Abstract] [Full Text] [Related]
38. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.
D'Angelo S; Cutro MS; Lubrano E; Leccese P; Mennillo GA; Ferrara N; Olivieri I
Ann Rheum Dis; 2010 May; 69(5):934-5. PubMed ID: 19666936
[No Abstract] [Full Text] [Related]
39. Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis.
Lee HC; Tsai TF
J Am Acad Dermatol; 2011 May; 64(5):1006-7. PubMed ID: 21496717
[No Abstract] [Full Text] [Related]
40. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
Magliocco MA; Gottlieb AB
J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
